Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has announced that Dr Rick Strassman, author of the book DMT: The Spirit Molecule and an Algernon.
Most books are either written to convey information and evoke understanding or to entertain while inspiring emotions and wonder. And they almost always do
A Vancouver company will soon be dosing patients in a new clinical study aimed at benefitting people who have suffered the negative neurological impact of strokes.
Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.